The Effect of Food on the Pharmacokinetics of Zileuton
- 1 January 1995
- journal article
- clinical trial
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 29 (Supplement) , 62-66
- https://doi.org/10.2165/00003088-199500292-00009
Abstract
The present study was undertaken to assess the effect of food on the pharmacokinetic parameters of zileuton. In a nonblinded crossover study, 18 healthy male volunteers who had fasted overnight were randomised to receive a single oral dose of zileuton 600mg in the presence or absence of food consisting of a standardised breakfast on the following morning. The mean zileuton peak plasma concentration (Cmax) increased significantly by 27% after food intake, while the mean area under the plasma concentration versus time curve increased by only 1.4%, a difference that was not statistically significant. The mean time to Cmax was unaffected by the presence of food, as were the other pharmacokinetic parameters assessed. Overall, the results suggest that food has a relatively small effect on the rate of zileuton absorption compared with the fasting state, while the bioavailability of the drug appears to be unaffected. Thus, it is concluded that it is appropriate to administer zileuton with or without food.Keywords
This publication has 10 references indexed in Scilit:
- The Pharmacokinetics of Single Oral Doses of Zileuton 200 to 800mg, its Enantiomers, and its Metabolites, in Normal Healthy VolunteersClinical Pharmacokinetics, 1995
- Determination of a New 5-Lipoxygenase Inhibitor, Zileuton, and its Inactive N-Dehydroxylated Metabolite in Plasma by High Performance Liquid ChromatographyClinical Pharmacokinetics, 1995
- The Effect of Inhibition of 5-Lipoxygenase by Zileuton in Mild-to-Moderate AsthmaAnnals of Internal Medicine, 1993
- The 5-lipoxygenase inhibitor zileuton blocks antigen-induced late airway responses, inflammation and airway hyperresponsiveness in allergic sheepEuropean Journal of Pharmacology, 1992
- Phase II study of the safety and efficacy of a 5-lipoxygenase inhibitor in patients with ulcerative colitis.1992
- 5-lipoxygenase inhibitory activity of zileuton.1991
- Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients.Thorax, 1991
- The Effects of a 5-Lipoxygenase Inhibitor on Asthma Induced by Cold, Dry AirNew England Journal of Medicine, 1990
- Selective 5-lipoxygenase inhibition in ulcerative colitisThe Lancet, 1990
- The effects of food on drug bioavailability.British Journal of Clinical Pharmacology, 1989